AzTrials
AzTrials

Laparoscopic Percutaneous Extra-peritoneal ClosureNCT07102277

Laparoscopic Percutaneous Extra-peritoneal Closure of the Internal Ring With or Without Peritoneal Cauterization

An observational study of Laparoscopic Percutaneous Extra-peritoneal Closure and Internal Ring, run by Tanta University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This research project aims to evaluate pediatric patients who underwent laparoscopic Percutaneous Internal Ring Suturing (PIRS) for inguinal hernia. Read more about this study

Who is it for?
Ages 3 months to 12 years
What is being tested?
Percutaneous Internal Ring Suturing (PIRS) with peritoneal cauterization and Percutaneous Internal Ring Suturing
Type of treatment
Surgery or procedure
How many people
270 participants
Where
1 siteEgypt
Study dates
1 Jan 2023to 30 Dec 2024
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 3 months to 12 years
  • All sexes
  • No healthy volunteers
  • Child

Study population: This is a retrospective comparative cohort study, evaluating pediatric patients who underwent Laparoscopic Percutaneous Internal Ring Suturing (PIRS) for inguinal hernia between [January 2023] and [December 2024].

Who may be able to join

  • Pediatric patients (3 months to 12 years) with diagnosed inguinal hernia.
  • Underwent Laparoscopic Percutaneous Internal Ring Suturing (PIRS).
  • Clear documentation of whether cauterization was performed.
  • At least 6 months of postoperative follow-up available.

Who cannot join

  • Recurrent or complicated hernias (incarcerated/strangulated).
  • Previous abdominal or pelvic surgery.
  • Missing or incomplete surgical records.
  • Less than 6 months of follow-up.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Tanta University

    Tanta, El-Gharbia, 31527

Other trials in Egypt

About this study

Official title: Outcome of Laparoscopic Percutaneous Extra-peritoneal Closure of Internal Ring With or Without Peritoneal Cauterization

This research project aims to evaluate pediatric patients who underwent laparoscopic Percutaneous Internal Ring Suturing (PIRS) for inguinal hernia.

Read the detailed description

Inguinal hernia repair is the most common procedure performed by pediatric surgery trainees. Open hernia repair (OH) is considered the gold standard approach for children; however, laparoscopic repair (LR) has recently emerged as an alternative option.

Laparoscopic percutaneous extraperitoneal closure of internal inguinal ring (Laparoscopic Percutaneous Internal Ring Suturing) (PIRS) is one of the plainest and most dependable operations for pediatric inguinal hernia.

Being tested
Percutaneous Internal Ring Suturing (PIRS) with peritoneal cauterization, Percutaneous Internal Ring Suturing

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Percutaneous Internal Ring Suturing (PIRS) with peritoneal cauterizationProcedure or surgery

    Percutaneous Internal Ring Suturing with peritoneal cauterization at the internal ring.

  • Percutaneous Internal Ring SuturingProcedure or surgery

    Percutaneous Internal Ring Suturing (PIRS) without peritoneal cauterization.

Study groups in NCT07102277
Study groupRoleWhat they receive
Group APercutaneous Internal Ring Suturing (PIRS) with peritoneal cauterization at the internal ring.
Receives: Procedure: Percutaneous Internal Ring Suturing (PIRS) with peritoneal cauterization
Group BPercutaneous Internal Ring Suturing (PIRS) without peritoneal cauterization.
Receives: Procedure: Percutaneous Internal Ring Suturing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Incidence of recurrence

    Incidence of recurrence was recorded.

    Measured: 1 year post-procedure

Secondary outcomes (2)
  1. Incidence of postoperative complications

    Incidence of postoperative complications such as seroma, hematoma, hydrocele, and wound infection were recorded.

    Measured: 24 hours postoperatively

  2. Degree of pain

    Degree of pain was assessed using Face, Legs, Activity, Cry, Consolability scale (FLACC) in patients <7 years, or using the visual analog scale (VAS)(0 represents "no pain" while 10 represents "the worst pain imaginable") in patients≥7 years.

    Measured: 24 hours postoperatively

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted3 Aug 2025
  2. Study start1 Jan 2023
  3. Primary completion30 Dec 2024
  4. Study completion30 Dec 2024

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Retrospective
Enrolment
270 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07102277
Sponsor's protocol ID
REC 713
Status last verified
Jul 2025
First submitted
28 Jul 2025
Last updated
3 Aug 2025
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The data will be available upon a reasonable request from the corresponding author after the end of study for one year.

Questions about this trial

What is this clinical trial studying?

An observational study of Laparoscopic Percutaneous Extra-peritoneal Closure and Internal Ring, run by Tanta University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 3 Aug 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Incidence of recurrence (time frame: 1 year post-procedure). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Aug 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in